Royalty Pharma Stock Price Target
Their forecasts range from $46.00 to $50.00. View 16 reports from 9 analysts offering long term price targets for gail (india) ltd.
It sold shares at $28 apiece, having last week set a target price range for the ipo of between $25 and $28 per share.
Royalty pharma stock price target. Some yellow flags with royalty pharma stock that said, there are a few reasons for caution. Stock advisor list price is $199 per year. View royalty pharma rprx investment & stock information.
With zomedica corp stock trading at $0.38 per share, the total value of zomedica corp stock (market capitalization) is $528.16m. The consensus estimate represents an upside of 35.01% from the last price of 130.55. Forma therapeutics started t outperform with $60 stock price target at oppenheimer feb.
Stock advisor launched in february of 2002. The average true range (atr) for royalty pharma plc is set at 1.08, with the price to sales ratio for rprx stock in. 3 wall street analysts that have issued a 1 year vale price target, the average vale price target is $15.33, with the highest vale stock price forecast at $18.00 and the lowest vale stock price forecast at $13.00.
Rprx) went public on june 16, 2020. On average, they expect royalty pharma's share price to reach $48.67 in the next year. What does royalty pharma do?
Invest in direct mutual funds & new fund offer (nfo) discover 5000+ schemes. Royalty pharma plc analyst ratings, historical stock prices, earnings estimates & actuals. Rprx updated stock price target summary.
According to the issued ratings of 3 analysts in the last year, the consensus rating for royalty pharma stock is buy based on the current 1 hold rating and 2 buy ratings for rprx. 17, 2021 at 8:24 a.m. Has an average target of 176.25.
Fair value is the appropriate price for the shares of a. The company debuted yesterday at an ipo price of $28 and the stock price went as high as $51.43 over the today (as of wednesday morning). The new note on the price target was released on november 09, 2020, representing the official price target for royalty pharma plc stock.
This suggests a possible upside of 17.1% from the stock's current price. Royalty pharma plc (rprx) stock forecast and price target. Et by tomi kilgore forma therapeutics started at outperform with $54 stock price.
The top end of the range values the company at $16.67 billion. Royalty pharma essentially helps biopharmaceutical companies by funding drug development in exchange for a percentage of future sales that the drugs may generate.
Posting Komentar untuk "Royalty Pharma Stock Price Target"